Fundz

Mediqstar closes a pre-Series B funding round from Genaxis to accelerate overseas commercialization of its AI-powered TB diagnostic platform. The amount raised was not disclosed.

PRIVATEAug 03, 2026

Round Type

Series B

South KoreaBiotechnologyHealth CareArtificial IntelligenceMedicalMedical DeviceMachine LearningHealth Diagnostics

Investors

Genaxis

Description

Mediqstar, a South Korean medical AI startup, has completed a pre-Series B funding round with Genaxis as the sole investor. The new capital will be used to advance the commercialization of its tuberculosis diagnostic solution, MycoScan, and R&D for colorectal cancer diagnostics. Genaxis decided to provide follow-on capital after evaluating Mediqstar’s technology and commercialization potential. MycoScan has received medical device approval in Korea and aims to enhance TB diagnostics.

Company Information

Company

Mediqstar

Location

South Korea

About

Mediqstar is a South Korean startup specializing in medical AI and large language models. It has developed MycoScan, an AI-powered tuberculosis diagnostic microscopy platform that operates in standard environments without the need for high-performance GPU servers. The company is expanding into colorectal cancer diagnostics with an integrated medical AI system using advanced data analysis techniques. Mediqstar is actively pursuing business partnerships in regions with high TB prevalence to expand its impact.

Fundz sees it the moment Mediqstar raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Mediqstar's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Mediqstar raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.